Dataset Information


2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.

ABSTRACT: The disease, COVID-19, is caused by the severe acute respiratory coronavirus 2 (SARS-CoV-2) for which there is currently no treatment. The SARS-CoV-2 main protease (Mpro) is an important enzyme for viral replication. Small molecules that inhibit this protease could lead to an effective COVID-19 treatment. The 2-pyridone scaffold was previously identified as a possible key pharmacophore to inhibit SARS-CoV-2 Mpro. A search for natural, antimicrobial products with the 2-pyridone moiety was undertaken herein, and their calculated potency as inhibitors of SARS-CoV-2 Mpro was investigated. Thirty-three natural products containing the 2-pyridone scaffold were identified from the literature. An in silico methodology using AutoDock was employed to predict the binding energies and inhibition constants (Ki values) for each 2-pyridone-containing compound with SARS-CoV-2 Mpro. This consisted of molecular optimization of the 2-pyridone compound, docking of the compound with a crystal structure of SARS-CoV-2 Mpro, and evaluation of the predicted interactions and ligand-enzyme conformations. All compounds investigated bound to the active site of SARS-CoV-2 Mpro, close to the catalytic dyad (His-41 and Cys-145). Thirteen molecules had predicted Ki values <1 ?M. Glu-166 formed a key hydrogen bond in the majority of the predicted complexes, while Met-165 had some involvement in the complex binding as a close contact to the ligand. Prominent 2-pyridone compounds were further evaluated for their ADMET properties. This work has identified 2-pyridone natural products with calculated potent inhibitory activity against SARS-CoV-2 Mpro and with desirable drug-like properties, which may lead to the rapid discovery of a treatment for COVID-19.

SUBMITTER: Forrestall KL 

PROVIDER: S-EPMC7710351 | BioStudies | 2021-01-01

REPOSITORIES: biostudies

Similar Datasets

2021-01-01 | S-EPMC7825698 | BioStudies
2021-01-01 | S-EPMC7850424 | BioStudies
2021-01-01 | S-EPMC7839507 | BioStudies
2021-01-01 | S-EPMC7547581 | BioStudies
2021-01-01 | S-EPMC7919488 | BioStudies
2021-01-01 | S-EPMC7938350 | BioStudies
2020-01-01 | S-EPMC7836334 | BioStudies
2020-01-01 | S-EPMC7347502 | BioStudies
2020-01-01 | S-EPMC7430054 | BioStudies
2020-01-01 | S-EPMC7463875 | BioStudies